# PPSV23 Pneumococcal Vaccine in Chronic Obstructive Pulmonary Disease (COPD)

> **NCT01381367** · PHASE4 · COMPLETED · sponsor: **Far Eastern Memorial Hospital** · enrollment: 38 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **BIOLOGICAL:** PPSV23 pneumococcal vaccine (Pneumovax®)
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT01381367
- **Lead sponsor:** Far Eastern Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2011-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01381367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01381367, "PPSV23 Pneumococcal Vaccine in Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01381367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*